AI assistant
Sending…
RIGEL PHARMACEUTICALS INC — Director's Dealing 2011
Feb 3, 2011
32801_dirs_2011-02-03_3bdc6772-6a3f-423b-a6cb-88b4bc80e9b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2011-02-01
Reporting Person: GOWER JAMES M (Director, CEO & Board Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-01 | Stock Option (Right to Buy) | $6.73 | A | 65000 | Acquired | 2021-02-01 | Common Stock (65000) | Direct |
Footnotes
F1: Vests monthly over one (1) year from January 1, 2011.
More from RIGEL PHARMACEUTICALS INC
Board/Management Information
2026
Jul 1
Regulatory Filings
2026
Jun 17
Call Transcript
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Call Transcript
2026
May 19
Call Transcript
2026
May 12
Regulatory Filings
2026
May 12
Call Transcript
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27